 |
Technical Support
(877) SEPAX-US, press 3  TechSupport@sepax-tech.com |
  |
Sample: Vaccine/VLP/NanoparticleVaccine/VLP/Nanoparticle Recommended products
Size Exclusion:
SRT
SRT-C
Preparative SEC
Ion Exchange: Proteomix Antibodix Reversed phase: Proteomix RP Bio-C4 |
Application Note
Featured Application Notes
All Application Notes
| App ID | Title |
| LR2024051506 | Literature Reference: Mosaic Quadrivalent Influenza Vaccine Single Nanoparticle Characterization |
| AAV7 | Analytical Characterization of AAV 2/8/9 Serotypes |
| AAV6 | Advanced SRT SEC 750 A for Optimal AAV Analysis |
| SV1007 | Adeno-Associated Virus (AAV5) Separation with Sepax SEC columns |
| SZ1001 | Large Pore SEC (1000 Å and 2000 Å) for Large Biomolecule Separation |
| ZZ1001 | Vaccine Analysis on SRT-2000 |
| SR1003 | Cas9 mRNA and FLuc mRNA |
| LR2022024 | Literature Reference: Characterization and Identification of Adeno of Adena Associated Vectors by SEC and MALS |
| LR2022021043 | Literature Reference: Titer measurement of HIV-1 envelope trimeric glycoprotein in cell culture media by a new tandem ion exchange and size exclusion chromatography (IEC-SEC) method. |
| a1t0h0000026Bkh | Literature Reference: High-throughput characterization of virus-like particles by interlaced size-exclusion chromatography |
| SV1006 | SV1006: VLP analysis on Large Pore Size SEC-MALS |
| EV1001 | Liposome Encapsulated Drugs Analysis on SEC |
| SV1002 | Analysis of a Virus Like Particle (VLP) on SRT SEC |
| SV1001 | Vaccine Analysis on SRT-2000 |